Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $12.1 million.

  • Rhythm Pharmaceuticals' Non-Current Assets fell 4803.5% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year decrease of 3732.52%. This contributed to the annual value of $18.1 million for FY2024, which is 2616.33% down from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Non-Current Assets of $12.1 million as of Q3 2025, which was down 4803.5% from $12.1 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Non-Current Assets' 5-year high stood at $31.4 million during Q1 2022, with a 5-year trough of $9.9 million in Q2 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $23.2 million (2024), whereas its average is $21.6 million.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Non-Current Assets soared by 26287.97% in 2021, and later crashed by 5076.39% in 2025.
  • Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Non-Current Assets stood at $21.1 million in 2021, then skyrocketed by 33.63% to $28.2 million in 2022, then decreased by 13.34% to $24.5 million in 2023, then fell by 26.16% to $18.1 million in 2024, then tumbled by 33.2% to $12.1 million in 2025.
  • Its Non-Current Assets was $12.1 million in Q3 2025, compared to $12.1 million in Q2 2025 and $17.4 million in Q1 2025.